TY - JOUR
T1 - Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study
AU - Coratti, Giorgia
AU - Pane, Marika
AU - Brogna, Claudia
AU - D'Amico, Adele
AU - Pegoraro, Elena
AU - Bello, Luca
AU - Sansone, Valeria A.
AU - Albamonte, Emilio
AU - Ferraroli, Elisabetta
AU - Mazzone, Elena Stacy
AU - Fanelli, Lavinia
AU - Messina, Sonia
AU - Sframeli, Maria
AU - Catteruccia, Michela
AU - Cicala, Gianpaolo
AU - Capasso, Anna
AU - Ricci, Martina
AU - Frosini, Silvia
AU - De Luca, Giacomo
AU - Rolle, Enrica
AU - De Sanctis, Roberto
AU - Forcina, Nicola
AU - Norcia, Giulia
AU - Passamano, Luigia
AU - Scutifero, Marianna
AU - Gardani, Alice
AU - Pini, Antonella
AU - Monaco, Giulia
AU - D'Angelo, Maria Grazia
AU - D'Angelo Bozzi, Michele Giovanni
AU - Leone, Daniela
AU - Zanin, Riccardo
AU - Zanin, Renata
AU - Vita, Gian Luca
AU - Panicucci, Chiara
AU - Bruno, Claudio
AU - Mongini, Tiziana
AU - Ricci, Federica
AU - Berardinelli, Angela
AU - Battini, Roberta
AU - Masson, Riccardo
AU - Baranello, Giovanni
AU - Dosi, Claudia
AU - Bertini, Enrico
AU - Bertini, Enrico Silvio
AU - Nigro, Vincenzo
AU - Politano, Luisa
AU - Mercuri, Eugenio Maria
PY - 2024
Y1 - 2024
N2 - Duchenne muscular dystrophy (DMD) is a neuromuscular condition characterized by muscle weakness. The Performance of upper limb (PUL) test is designed to evaluate upper limb function in DMD patients across three domains. The aim of this study is to identify frequently lost or gained PUL 2.0 abilities at distinct functional stages in DMD patients. This retrospective study analyzed prospectively collected data on 24-month PUL 2.0 changes related to ambulatory function. Ambulant patients were categorized based on initial 6MWT distance, non-ambulant patients by time since ambulation loss. Each PUL 2.0 item was classified as shift up, no change, or shift down. The study's cohort incuded 274 patients, with 626 paired evaluations at the 24-month mark. Among these, 55.1 % had activity loss, while 29.1 % had gains. Ambulant patients showed the lowest loss rates, mainly in the shoulder domain. The highest loss rate was in the shoulder domain in the transitioning subgroup and in elbow and distal domains in the non-ambulant patients. Younger ambulant patients demonstrated multiple gains, whereas in the other functional subgroups there were fewer gains, mostly tied to singular activities. Our findings highlight divergent upper limb domain progression, partly linked to functional status and baseline function.
AB - Duchenne muscular dystrophy (DMD) is a neuromuscular condition characterized by muscle weakness. The Performance of upper limb (PUL) test is designed to evaluate upper limb function in DMD patients across three domains. The aim of this study is to identify frequently lost or gained PUL 2.0 abilities at distinct functional stages in DMD patients. This retrospective study analyzed prospectively collected data on 24-month PUL 2.0 changes related to ambulatory function. Ambulant patients were categorized based on initial 6MWT distance, non-ambulant patients by time since ambulation loss. Each PUL 2.0 item was classified as shift up, no change, or shift down. The study's cohort incuded 274 patients, with 626 paired evaluations at the 24-month mark. Among these, 55.1 % had activity loss, while 29.1 % had gains. Ambulant patients showed the lowest loss rates, mainly in the shoulder domain. The highest loss rate was in the shoulder domain in the transitioning subgroup and in elbow and distal domains in the non-ambulant patients. Younger ambulant patients demonstrated multiple gains, whereas in the other functional subgroups there were fewer gains, mostly tied to singular activities. Our findings highlight divergent upper limb domain progression, partly linked to functional status and baseline function.
KW - Duchenne muscular dystrophy
KW - Performance of upper limb
KW - Shift analysis
KW - Upper limb disease progression
KW - Upper limb function
KW - Duchenne muscular dystrophy
KW - Performance of upper limb
KW - Shift analysis
KW - Upper limb disease progression
KW - Upper limb function
UR - http://hdl.handle.net/10807/260291
U2 - 10.1016/j.nmd.2023.11.011
DO - 10.1016/j.nmd.2023.11.011
M3 - Article
SN - 0960-8966
VL - 34
SP - 75
EP - 82
JO - Neuromuscular Disorders
JF - Neuromuscular Disorders
ER -